US FDA Staff Cuts: Biopharma Industry Braces For Impact, But First Wants Clarity On Losses

Stakeholders are waiting for the dust to settle to better understand who was laid off as part of the Trump Administration's cuts at the FDA, the reductions' impact on applications currently under review and broader drug development efforts.